Pfizer Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $22.99B
| Line Item | Value | % of Total |
|---|---|---|
| Stock Repurchases | $9.22B | 40.1% |
| Other Financing | $6.16B | 26.8% |
| Working Capital | $2.63B | 11.5% |
| Other | $4.97B | 21.6% |
| Net Cash Flow | $0 | 0.0% |